It's officially October and I couldn't be more excited…
Most traders don't know this, but every year a small yet profitable trading window opens up in the fall…
It allows investors to turn just a few hundred bucks into what could be a couple thousand — especially since the string of major biotech conferences has officially begun, supplying the stock market with catalyst after catalyst.
And if these stocks are played the right way… it can be incredibly lucrative for people like us.
It's already happened with Trillium Therapeutics (Nasdaq: TRIL) and Ocular Therapeutix (Nasdaq: OCUL).
With these babies in my account, I've been hitting 52-week highs every day this week.
These two biotech stocks have been outperforming every expectation I had when I recommended them to my Free Riders Club. And they keep surprising me…
These trades have gone up 20% and 50% — in a couple of days! And traders didn't even have to risk a single penny of their starting capital.
And I have even more good news about OCUL that I'll explain in my video… |
0 Response to "2 Booming Biotech Stocks to Buy"
Post a Comment